ATTRv-PN Treatment Vutrisiran Demonstrates Long-Term
Efficacy in Open-Label HELIOS-A Extension
New findings confirm vutrisiran's long-term safety and efficacy in treating hereditary transthyretin amyloidosis, enhancing patient…














